Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,602 public trials 545 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Active, Not Recruiting

Isa-Pom-Dex in Elderly/Frail Subjects With RRMM

NCT05911321

Conditions
Aging, Blood Protein Disorders, Cardiovascular Diseases, +20 more
Locations
  • Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • Atrium Health Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States
View Trial Details
Active, Not Recruiting

A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment

NCT05455320

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Norwalk Hospital-oncology Norwalk, Connecticut, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
View all 216 locations
View Trial Details
Active, Not Recruiting

Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

NCT04176718

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +19 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

MMRC Horizon One: RRMM (MMRC-099)

NCT06171685

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • City of Hope Duarte, California, United States
  • Emory Winship Cancer Center Atlanta, Georgia, United States
  • University of Chicago Cancer Center Chicago, Illinois, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Study of Elranatamab for Relapsed or Refractory Myeloma in Patients Previously Exposed to Three-drug Classes

NCT06282978

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Hospital Clínico Universitario de Santiago ~ CHUS Santiago de Compostela, A Coruña, Spain
  • Hospital Son Llàtzer Palma de Mallorca, Balearic Islands, Spain
  • Institut Catala d'Oncologia (ICO) Badalona - Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain
View all 13 locations
View Trial Details
Active, Not Recruiting

KRDI in Transplant-Eligible MM

NCT04430894

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide

NCT05434689

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ohio State University Medical College Columbus, Ohio, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • University of Wisconsin Madison, Wisconsin, United States
View Trial Details

Related conditions